Earnings Preview For ImmunoPrecise Antibodies
Portfolio Pulse from Benzinga Insights
ImmunoPrecise Antibodies (NASDAQ:IPA) is scheduled to release its quarterly earnings report on Thursday, 2023-12-14, with analysts expecting an EPS of $-0.10. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, IPA's stock price has reacted negatively to past earnings reports, even with an EPS beat last quarter resulting in a 12.0% share price drop. Over the last year, IPA shares have declined by 74.49%, indicating a bearish sentiment among long-term shareholders.
December 13, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ImmunoPrecise Antibodies is expected to report an EPS of $-0.10 for the upcoming earnings, with investors hoping for positive guidance. Historical data shows negative stock reactions to earnings reports, and a 74.49% annual decline suggests bearish sentiment.
Given the historical negative reaction to earnings reports and the significant annual decline in stock price, it is likely that IPA's stock may experience a short-term drop post-earnings, especially if the company fails to meet or exceed the EPS estimate or provide strong future guidance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100